EMBARGOED FOR RELEASE UNTIL 4 PM ET, October 21, 2026

After stroke and AFib, restoring heart rhythm linked to lower risk of another stroke

EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, OCTOBER 21, 2026

Highlights:

• A new study looked at people hospitalized with both ischemic stroke and AFib, an irregular heartbeat that can raise stroke risk.
•  People who received treatment to restore a normal heart rhythm within eight weeks had a lower risk of another stroke or blood clot.
• Over five years, the risk of another stroke or blood clot was 8% for those who received early rhythm control, compared with 14% for those who did not.
•  Researchers found early rhythm control was associated with a 44% lower risk of another stroke or blood clot.
• The study does not prove that early rhythm control prevents second stroke, it only shows an association.

MINNEAPOLIS — For people hospitalized with ischemic stroke and atrial fibrillation (AFib), restoring the heart’s normal rhythm within eight weeks after stroke is associated with a lower risk of having another stroke, according to a new study published October 21, 2026, in Neurology®, the official medical journal of the American Academy of Neurology. Ischemic stroke, the most common type of stroke, is when blood flow is blocked to part of the brain. The study does not prove that early rhythm control prevents a second stroke, it only shows an association.

Atrial fibrillation is an irregular and often very rapid heartbeat. Early rhythm control restores the heart’s normal rhythm, either with medication; electrical cardioversion, which is a quick electrical shock; or catheter ablation, which uses heat, cold or electricity to create a scar to block abnormal electrical impulses.

“With just atrial fibrillation, restoring the heart’s normal rhythm early reduces the risk of cardiovascular events later,” said study author Yuichi Imanaka, MD, MPH, PhD, of Kyoto University in Japan. “But less is known about the combination of ischemic stroke and AFib. Our study shows when a person has both stroke and AFib, early rhythm control is associated with a reduced risk of a second stroke.”

For the study, researchers identified 14,355 people with an average age of 83 who were admitted to a hospital with both ischemic stroke and AFib. Of participants, 2%, or 268 people, received early rhythm control: 206 received medication; 68 had catheter ablation; and 32 had electrical cardioversion. Some people had more than one of these treatments.

Researchers then looked at how many people were hospitalized again for a second ischemic stroke or a systemic embolism, a blood clot that occurs in another part of the body.

Over 23,583 person-years, 1,257 people had another stroke or blood clot. Of this group, 13 had received early rhythm control and 1,244 had not. Person-years represent both the number of people in the study and the amount of time each person spent in the study.

Researchers used a method to adjust for differences between the groups based on factors such as other medical conditions, frailty and stroke severity.

Over five years, researchers determined that people who received early rhythm control had an 8% risk of a second stroke or blood clot compared to a 14% risk for people who did not receive such treatment.

Researchers found early rhythm control was associated with a 44% lower risk of stroke and blood clot.

They also found that early rhythm control was associated with a 28% lower risk of death from all possible causes.

“People who have an ischemic stroke are prescribed anticoagulants, medications that stop the blood from clotting easily, to prevent a second stroke,” said Imanaka. “Our study suggests that early rhythm control may serve as another prevention strategy, with flexible timing of initiation, within eight weeks of stroke.”

A limitation of the study was the small number of participants who received early rhythm control. Imanaka says future studies are needed in larger groups of people to confirm the findings.

The study was supported by the Japan Society for the Promotion of Science.

Discover more about stroke at BrainHealth.com, a free public resource from the American Academy of Neurology. It offers a website, podcast, and books, connecting you with trusted information from the world’s leading experts in brain health. Follow BrainHealth.com on Facebook, X, and Instagram.

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.